机构:[a]Department of Neurobiology and Center of Stroke, Beijing Institute for Brain Disorders, School of Basic Medical Science, Capital Medical University, Beijing, China[b]Inner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China[c]Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China科技平台低氧适应转化医学北京市重点实验室首都医科大学宣武医院[d]Department of Oral and Maxillofacial Surgery, University of California San Francisco, San Francisco, USA[e]Department of neurosurgery, the First Affiliated Hospital of Baotou Medical College, Inner Mongolia, China外科系统神经外科江苏省人民医院
This project was supported by the National Key R&D Program of China ( 2017YFC1308405 ), National Natural Science Foundation of China (Nos. 81460283 , 81660307 ), Inner Mongolia Science Foundation (Nos. 2018 LH08078 , 2016MS(LH)0307 ), Inner Mongolia Educational Research Foundation (Nos. NJZY17243 , NJZY17250 , NJZY17251 ) and Baotou medical college Foundation ( BYJJ-DF201602 , BYJJ-QM201656 , BYJJ201502 ).
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类|3 区医学
小类|3 区医学:研究与实验3 区药学
最新[2023]版:
大类|2 区医学
小类|1 区药学2 区医学:研究与实验
JCR分区:
出版当年[2017]版:
Q2PHARMACOLOGY & PHARMACYQ2MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY
第一作者机构:[a]Department of Neurobiology and Center of Stroke, Beijing Institute for Brain Disorders, School of Basic Medical Science, Capital Medical University, Beijing, China[b]Inner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China[c]Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China
通讯作者:
通讯机构:[a]Department of Neurobiology and Center of Stroke, Beijing Institute for Brain Disorders, School of Basic Medical Science, Capital Medical University, Beijing, China[b]Inner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China[c]Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China[*1]Department of Neurobiology and Center of Stroke, Beijing Institute for Brain Disorders, School of Basic Medical Science, Capital Medical University, Beijing, China
推荐引用方式(GB/T 7714):
Ruifang Qi,Xiaolu Zhang,Yabin Xie,et al.5-Aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathway[J].BIOMEDICINE & PHARMACOTHERAPY.2019,118:109219.doi:10.1016/j.biopha.2019.109219.
APA:
Ruifang Qi,Xiaolu Zhang,Yabin Xie,Shuyuan Jiang,You Liu...&Guo Shao.(2019).5-Aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathway.BIOMEDICINE & PHARMACOTHERAPY,118,
MLA:
Ruifang Qi,et al."5-Aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathway".BIOMEDICINE & PHARMACOTHERAPY 118.(2019):109219